MUMBAI, India, Oct. 19 -- Intellectual Property India has published a patent application (202647121993 A) filed by Fortvita Biologics Inc. on October 12, 2026, for Anti-Dll3 Antibody And Use Thereof.
Inventors include Wu, Weiwei; Li, Li; and Feng, Ye.
The application for the patent was published on October 16, 2026, under issue no. 42/2026.
Abstract: Provided are an antibody or an antigen-binding fragment thereof, the antibody or the antigen-binding fragment thereof being able to specifically bind to a DLL3 protein, such as human DLL3 protein. Also provided is a multispecific binding molecule that specifically binds to DLL3 and one or more tumor-associated antigens. Further provided are a nucleic acid molecule encoding the antibody, an e...